Table 2 Pathological analysis of lesions.

From: Different clinicopathological features between young and older patients with pulmonary adenocarcinoma and ground-glass opacity

Characteristics

Young (n = 103), n (%)

Elder (n = 100), n (%)

p value

Pathology

  

 < 0.001

 AIS

1 (0.97)

1 (1.00)

 

 MIA

72 (69.90)

19 (19.00)

p < 0.05

 IAC

30 (29.13)

80 (80.00)

p < 0.05

Predominant subtype

  

0.546

 Acinar

12 (40.00)

34 (42.50)

 

 Papillary

3 (10.00)

9 (11.25)

 

 Lepidic

14 (46.67)

37 (46.25)

 

 Solid

1 (3.33)

0 (0)

 

Degree of differentiation

  

 < 0.001

 Well

5 (16.67)

11 (13.75)

 

 Well-moderately

12 (40.00)

31 (38.75)

 

 Moderately

4 (13.3)

33 (41.25)

p < 0.05

 Moderately poorly

7 (23.3)

2 (2.50)

p < 0.05

 Poorly

1 (3.33)

0 (0)

 

 Unknown

1 (3.33)

3 (3.75)

 

TNM stage

  

 < 0.001

 I A1

57 (55.34)

13 (13.00)

p < 0.05

 I A2

31 (30.10)

29 (29.00)

 

 I A3

2 (1.94)

24 (24.00)

p < 0.05

 I B

4 (3.88)

29 (29.00)

p < 0.05

 II A

3 (2.91)

3 (3.00)

 

 II B

2 (1.94)

1 (1.00)

 

 III A

3 (2.91)

1 (1.00)

 

 III B

0 (0)

0 (0)

 

 IV A

1 (0.97)

0 (0)

 

VPI

5 (4.85)

21 (21.00)

 < 0.001

VTT

2 (1.94)

1 (1.00)

0.551

LVI

4 (3.88)

2 (2.00)

0.355

STAS

5 (4.85)

18 (18.00)

0.003

  1. AIS adenocarcinoma in situ, MIA minimally invasive adenocarcinoma, IAC invasive adenocarcinoma, VPI visceral pleural invasion, VTT vascular tumor thrombus, LVI lymphovascular invasion, STAS spread through the airspace.